Toxicological evaluation of a dietary supplement formulated for male sexual health prior to market release

Regulatory Toxicology and Pharmacology

Volumn 57, Issue 1, 2010, Pages 55-61

  Clewell, A ^a   Qureshi, I ^a   Endres, J ^a   Horvath J ^b   Financsek, I ^b   Neal Kababick, J ^c   Jade, K ^a   Schauss, A G ^a  

^a AIBMR Life Sciences Inc   (United States)

^b Pharmaceutical Control and Development Laboratory   (Hungary)

^c Flora Research Laboratories   (United States)

Author keywords

A ai; AIBMR; Alternative medicine; Butea superba; Euterpe oleracea; Panax ginseng; Safety; Sexual functioning; Toxicology; Tribulus terrestris

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ACUTE TOXICITY; AMES TEST; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERECTILE DYSFUNCTION; FEMALE; FOOD SAFETY; IN VITRO STUDY; LD 50; MALE; MARKETING; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SEXUAL HEALTH; SEXUALITY; THERAPY EFFECT; TOXICITY TESTING;

ANIMALS; CHO CELLS; CONSUMER PRODUCT SAFETY; CRICETINAE; CRICETULUS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CONTAMINATION; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; LETHAL DOSE 50; MALE; MICE; MICE, INBRED BALB C; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTATION; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; SEXUAL BEHAVIOR; TOXICITY TESTS, CHRONIC;

BUTEA; EUTERPE OLERACEA; PANAX GINSENG; TRIBULUS TERRESTRIS;

EID: 77951978511     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2009.12.006     Document Type: Article

References (39)

1. Abe K., Saito H. Both oxidative stress-dependent and independent effects of amyloid B protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. Brain Res. 1999, 830:146-154.
2. Adimoelja A. Phytochemicals and the breakthrough of traditional herbs in the management of sexual dysfunctions. Int. J. Androl. 2000, 23(Suppl. 2):82-84.
3. Ames B.N., et al. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 1975, 31:347-364.
4. Anon, 2007. l-tyrosine. Monograph. Altern. Med. Rev. 12, 364-368.
5. Boorman, G.A., et al., 1990. Pathology of the Fisher Rat. Reference and Atlas. Academic press, Inc. Harcourt Brace Jovanovich, Publishers, San Diego, New York, Boston, London, Sidney, Tokyo, Toronto.
6. Cherdshewasart W., Nimsakul N. Clinical trial of Butea superba, an alternative herbal treatment for erectile dysfunction. Asian J. Androl. 2003, 5:243-246.
7. Choi Y.D., et al. In vitro and in vivo experimental effect of Korean red ginseng on erection. J. Urol. 1999, 162:1508-1511.
8. Cohen P.A. American roulette-contaminated dietary supplements. N. Engl. J. Med. 2009, 361:1523-1525.
9. Dollins A.B., et al. l-tyrosine ameliorates some effects of lower body negative pressure stress. Physiol. Behav. 1995, 57:223-230.
10. Ervin R.B., et al. Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988-94. Adv. Data. 2004, 349:1-7.
11. Fink H.A., et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch. Intern. Med. 2002, 162:1349-1360.
12. Gauthaman K., Ganesan A.P. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction-an evaluation using primates, rabbit and rat. Phytomedicine 2008, 15:44-54.
13. Goldstein I., et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med. 1998, 338:1397-1404.
14. Gratz S.R., et al. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J. Pharm. Biomed. Anal. 2004, 36:525-533.
15. Honzel D., et al. Comparison of chemical and cell-based antioxidant methods for evaluation of foods and natural products: generating multifaceted data by parallel testing using erythrocytes and polymorphonuclear cells. J. Agric. Food Chem. 2008, 56:8319-8325.
16. Jang D.J., et al. Red ginseng for treating erectile dysfunction: a systematic review. Br. J. Clin. Pharmacol. 2008, 66:444-450.
17. Langtry H.D., Markham A. Sildenafil: a review of its use in erectile dysfunction. Drugs 1999, 57:967-989.
18. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J. Neurosci. Methods 2000, 96:47-152.
19. Malaivijitnond S., et al. Different effects of Pueraria mirifica, a herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J. Pharmacol. Sci. 2004, 96:428-435.
20. Marinac J.S., et al. Herbal products and dietary supplements: a survey of use, attitudes, and knowledge among older adults. J. Am. Osteopath. Assoc. 2007, 107:13-23.
21. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
22. Noonan C., Noonan P.W. Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients. Toxicology 2006, 221:4-8.
23. Reepmeyer J.C., et al. Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement. J. Pharm. Biomed. Anal. 2007, 43:1615-1621.
24. Ryu J.K., et al. Free radical-scavenging activity of Korean red ginseng for erectile dysfunction in non-insulin-dependent diabetes mellitus rats. Urology 2005, 65:611-615.
25. Schauss A.G., et al. Antioxidant capacity and other bioactivities of the freeze-dried Amazonian palm berry, Euterpe oleraceae mart (acai). J. Agric. Food Chem. 2006, 54:8604-8610.
26. Sunwoo S., et al. Post-marketing surveillance study of the safety and efficacy of sildenafil prescribed in primary care to erectile dysfunction patients. Int. J. Impot. Res. 2005, 17:71-75.
27. Timbo B.B., et al. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J. Am. Diet. Assoc. 2006, 106:1966-1974.
28. United States Food and Drug Administration, 2001. Lipokinetix. Available from: <> (accessed 16.09.09). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172824.htm.
29. United States Food and Drug Administration, 2004. FDA Warns Consumers Not to Purchase Green Hornet, Promoted as Herbal Version of " Ecstasy" Available from: <> (accessed 16.09.09). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108249.htm.
30. United States Food and Drug Administration, 2005. Liqiang 4 Dietary Supplement Capsules. Available from: <> (accessed 16.09.09). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150476.htm.
31. United States Food and Drug Administration, 2006a. FDA Warns Consumers About Dangerous Ingredients in " Dietary Supplements" Promoted for Sexual Enhancement. Available from: <> (accessed 16.07.09). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108690.htm.
32. United States Food and Drug Administration, 2006b. FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients Emagrece Sim and Herbathin Dietary Supplements May be Harmful. Available from: <> (accessed 16.09.09). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108578.htm.
33. United States Food and Drug Administration, 2007a. FDA Requests Recall of 'True Man Sexual Energy,' 'Energy Max' Dietary Supplements. Available from: <> (accessed 16.07.09). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109020.htm.
34. United States Food and Drug Administration, 2007b. FDA Warns Consumers Not to Use Super Shangai, Strong Testis, Shangai Ultra, Shangai Ultra X, Lady Shangai, and Shangai Regular (also known as Shangai Chaojimengnan). Available from: <> (accessed 16.07.09). http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109049.htm.
35. United States Food and Drug Administration, 2007c. Final Rule for Current Good Manufacturing Practices (CGMPs) for Dietary Supplements. Available from: <> (accessed 30.07.08). http://edocket.access.gpo.gov/2007/07-3039.htm.
36. United States Food and Drug Administration, 2008. Hidden Risks of Erectile Dysfunction " Treatments" Sold Online. Available from: <> (accessed 16.07.09). http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048386.htm.
37. United States Food and Drug Administration, 2009a. Safety Alerts for Human Medical Products: Libipower Plus. Available from: <> (accessed 16.07.09). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm171914.htm.
38. United States Food and Drug Administration, 2009b. Safety Alerts for Human Medical Products: Stamina-Rx. Available from: <> (accessed 16.07.09). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm168017.htm.
39. Vandenberghe J. Life-span Data and Historical Control Data in Carcinogenicity Testing in Wistar Rats Crl:(Wi)Br 1993, Charles Riber, Deutschland.